Elsevier Science Inc.

SHERPA: Unknown

People

  1. Lewis
    Lewis
  2. Pillarsetty
    Pillarsetty
  3. Zeglis
    Zeglis
  4. Samuels
    Samuels
  5. Bauer
    Bauer
  6. Divilov
    Divilov
  7. Edwards
    Edwards
  8. Mandleywala
    Mandleywala
  9. Pratt
    Pratt
  10. Blasberg
    Blasberg

Groups

  1. Center for Pancreatic Cancer Research (38)
  2. GSK Faculty (37)
  3. Radiology, Department of (37)
  4. Radiochemistry and Imaging Sciences Service (36)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (18)
  6. Center for Molecular Imaging and Biotechnology (18)
  7. Sloan Kettering Institute Postdocs (18)
  8. MSK Grad Students (9)
  9. Sloan Kettering Institute Faculty (5)
  10. Molecular Pharmacology and Chemistry Program Faculty (4)
Search Within
  1. "Center for Pancreatic Cancer Research"
Formats
  1. Journal Article (19)
  2. Meeting Abstract (18)
  3. Editorial (1)
Groups
  1. Center for Pancreatic Cancer Research (38)
  2. GSK Faculty (37)
  3. Radiology, Department of (37)
  4. Radiochemistry and Imaging Sciences Service (36)
  5. Center for Molecular Imaging and Biotechnology (18)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (18)

More Groups

People
  1. Jason Lewis (35)
  2. Nagavarakishore Pillarsetty (9)
  3. Brian Zeglis (6)
  4. Zachary Samuels (4)
  5. David Bauer (3)
  6. Edwin Pratt (3)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (5)
  4. 2022 (8)
  5. 2021 (2)
  6. 2020 (3)

More Years

Publications
  1. Nuclear Medicine and Biology (36)
  2. NeoPlasia (2)

Results (38)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pretargeted alpha therapy in MUC16-positive high-grade serous ovarian cancer
    Journal Article

    Mack, K. N.; Bauer, D.; Carter, L. M.; Carrasco, S. E.; Atmane, M. I.; Viray, T. D.; Brooks, C. L.; Hollingsworth, M. A.; Radhakrishnan, P.; Lewis, J. S.
    Nuclear Medicine and Biology (2025)

    Fulltext@MSK | Save
  • NMB Innovators Series Professor Jon Dilworth: shining a light on the chemistry of metals used in biology, medicine and radiochemistry: With this series of editorials, NMB honors the scientists in the radiopharmaceutical sciences domain that have dedicated their career to our field and made substantial contributions
    Editorial

    Dilworth, J. R.; Lewis, J. S.; Pascu, S. I.
    Nuclear Medicine and Biology (2024)

    Fulltext@MSK | Save
  • [(89)Zr]ZrCl(4) for direct radiolabeling of DOTA-based precursors
    Journal Article

    Lyashchenko, S. K.; Tran, T.; Happel, S.; Park, H.; Bauer, D.; Jones, K.; Esposito, T. V.; Pillarsetty, N.; Lewis, J. S.
    Nuclear Medicine and Biology (2024)

    Fulltext@MSK | Save
  • Identifying lymph node metastasis in high grade serous ovarian cancer mouse models via ImmunoPET imaging
    Meeting Abstract

    Mack, K.; Mandleywala, K.; Samuels, Z.; Lewis, J.
    Nuclear Medicine and Biology (2023)

    Fulltext@MSK | Save
  • [(45(Ti]Ti-HOPO radiochemistry for development of PET radiopharmaceuticals
    Meeting Abstract

    Saini, S.; Bhupathiraju, Nvsd; Francesconi, L.; Deri, M.; Lewis, J.; Lapi, S.
    Nuclear Medicine and Biology (2023)

    Fulltext@MSK | Save
  • Development of a PSMA heterogeneous tumor model for targeted radiotherapy
    Meeting Abstract

    Payne, R.; Kalidindi, T.; Zurita, J.; Esposito, T.; Ponomarev, V.; Lewis, J.; Pillarsetty, N. V. K.
    Nuclear Medicine and Biology (2023)

    Fulltext@MSK | Save
  • Imaging lung tumor metastasis with (89)Zr-DFO-crizanlizumab targeting P-selectin
    Meeting Abstract

    Majekodunmi, O.; Pratt, E.; Kaminsky, S.; Raashed, R.; Heller, D.; Laplant, Q.; Lewis, J.
    Nuclear Medicine and Biology (2023)

    Fulltext@MSK | Save
  • Targeting brain tumours with radiolabelled chlorotoxin, a scorpion venom peptide
    Meeting Abstract

    Zafar, I.; Li, K.; Zammit, J.; Palm, K. P.; Davydova, M.; Varshney, M.; Lu, L.; Tran, T.; Bergstrom, T.; Swartling, F. J.; more...
    Nuclear Medicine and Biology (2023)

    Fulltext@MSK | Save
  • (89)Z-immuno-PET guided preclinical development of targeted therapies: Demonstrating utility by evaluating fusion proteins in vivo
    Meeting Abstract

    Herrero Alvarez, N.; Lewis, J.; Molvi, Z.; O'Reilly, R.; Nyakatura, E.; Balderes, P.; Viray, T.
    Nuclear Medicine and Biology (2022)

    Fulltext@MSK | Save
  • Investigating different chelators for a pretargeting approach with (203:212)Pb- and (64:67)Cu-labeled tetrazines
    Meeting Abstract

    Bauer, D.; Michel, A.; Kaminsky, S.; Li, M. S.; Schultz, M.; Saini, S.; Lapi, S.; Lewis, J.
    Nuclear Medicine and Biology (2022)

    Fulltext@MSK | Save

    • Elsevier Science Inc. – authorized name for: